Given that the Leerink firm just downgraded Merck about a week ago, there might be some testy lines of questioning.
. . . .Merck & Co., Inc. CFO Peter Kellogg
at Leerink Swann Global Healthcare Conference
Wednesday, February 13, 2013 11:30 a.m. ET. . . .
It turns out that I'll have to catch the replay -- as I am busy at that time, tomorrow -- but will post late in the day if anything truly significant is said.